Cipla, India’s leading pharmaceutical company, has said that its Q3FY11 net profit has fallen 19.5% on a year-on-year basis to Rs 232.7 crore from Rs 289 crore in the corresponding quarter of the previous year. However, its sales grew by 11.7% to Rs 1501.36 crore in the quarter ended December 2010 as against Rs 1344.16 crore during the same period.
The decline in net profit was led by lower operating margins which fell to 21.19% in Q3FY11 from 28.26% in the same quarter of the previous fiscal year.
You can contact the author at: businessbanter@gmail.com
No comments:
Post a Comment